GlassScriptPhysician profile
Ali Shafiq
NPI 1609005503
$11,693.41
in general payments reported to CMS, 2019-2025
12 companies · $1,284 in 2025
The $1,284 reported for 2025 was more than what 76% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $272 · 2020: $3,320 · 2021: $4,511 · 2022: $1,069 · 2023: $1,046 · 2024: $192 · 2025: $1,284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,034 · Food and Beverage: $488.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,033.65 |
| Food and Beverage | $488.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,039.88 | 2021-2022 | |
| Boston Scientific Corporation | $2,247.40 | 2022-2025 | Versacross Access Solution, Watchman Flx |
| Medtronic Vascular, INC. | $1,835.94 | 2020 | |
| Baylis Medical Company INC | $1,506.86 | 2021 | |
| Edwards Lifesciences Corporation | $1,050.10 | 2020-2024 | |
| W. L. Gore & Associates, INC. | $1,002.00 | 2023 | Gore Cardioform Septal Occluder |
| Abbott Laboratories | $481.82 | 2019-2021 | |
| Cardiovascular Systems INC. | $279.40 | 2019-2020 | |
| Abiomed | $168.52 | 2023-2024 | Impella |
| Novartis Pharmaceuticals Corporation | $29.46 | 2024 | |
| Heartflow, INC. | $28.29 | 2025 | |
| Janssen Pharmaceuticals, INC | $23.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Shafiq listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.